Quotes Raphael Pharmaceutical Inc.

Stocks

RAPH

US27785B2088

Biotechnology & Medical Research

Market Closed - OTC Markets 11:53:26 2026-07-28 EDT			5-day change	1st Jan Change
1.400 ^USD	-.--%		-.--%	-

08-14	Raphael Pharmaceutical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-17	Raphael Pharmaceutical Inc. Announces Board Resignations	CI

Stock exchange

OTC Markets RAPH 1.400 $ -.--% 319.2 $

Markets		Price	Change	Volumes
OTC Markets	RAPH	1.400USD	-.--%	319.2 $

Performance

1 year	+536.36%
3 years	+36.47%

Volumes

markets

Daily volume

228

Estimated daily volume

228

Record volume 1

4,320

Record volume 2

4,150

Record volume 3

3,115

Capital turnover ratio

Float rotation

Basic data

Market Cap (USD)

28,246,985

Net sales ()

Free-Float

53.88%

Free-Float capitalization (USD)

15,219,982

Indicators

Moving average 20 days

0.512

Moving average 50 days

0.2328

Moving average 100 days

0.9507

Price spread / (MMA20)

-63.43%

Price spread / (MMA50)

-83.37%

Price spread / (MMA100)

-32.09%

RSI 9 days

60.02

RSI 14 days

57.07

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RAPHAEL PHARMACEUTICAL INC.	-.--%	-.--%	+536.36%	+36.47%	28.25M
LONZA GROUP AG	-0.14%	+4.33%	+9.88%	+31.73%	47.97B
IQVIA HOLDINGS INC.	-1.69%	+1.48%	+53.02%	+33.59%	44.5B
REVOLUTION MEDICINES, INC.	+2.56%	+7.34%	+382.17%	+594.81%	43.93B
BEONE MEDICINES AG	+0.24%	+2.85%	+9.78%	+89.54%	41.03B
CELLTRION, INC.	-0.62%	-1.11%	+4.70%	+46.02%	29.85B
MEDPACE HOLDINGS, INC.	-0.28%	+1.07%	+26.83%	+152.91%	17.27B
EUROFINS SCIENTIFIC SE	-0.46%	+1.20%	+26.78%	+41.32%	15.3B
ASCENDIS PHARMA A/S	-2.21%	-4.70%	-	-	14.82B
TEMPUS AI, INC.	+3.37%	+9.21%	+9.93%	-	15.34B
Average	+0.08%	+1.44%	+117.72%	+128.30%	27B
Weighted average by Cap.	+0.11%	+1.79%	+83.08%	+156.20%